Chien-Wen Tseng, MD, MS, MPH

DFMCH Professor, Director of Research

Hawaii Medical Service Association Endowed Chair in Health Services and Quality Research

Contact Information

Email: cwtseng@hawaii.edu

 

Education

Undergraduate

Rice University, BS –  Electrical Engineering, BA – Mathematical Sciences

Graduate School

Stanford University, MS – Electrical Engineering

University of California, Los Angeles, School of Public Health, MPH

Medical School

University of California, Los Angeles, MD

Residency Training

Policy Internship, American Academy of Family Physicians, Robert Graham Center for Policy and Research

University of Washington, Family Medicine Residency Program

Fellowship Training

Robert Wood Johnson Foundation Clinical Scholars Program, University of California, Los Angeles

 

Clinical & Academic Roles

Medical Student Role

  • MS3 Clerkship Continuity Clinic Preceptor
  • Mentorship & Career Advising

Residency Role

  • Inpatient Team Care Attending (Pali Momi Medical Center)
  • Resident Continuity Clinic Preceptor

 

Research

Research Interests

  • Health Policy
  • Quality of Care
  • Cost of Care
  • Medicare
  • Drug Benefit Design
  • Preventive Care
  • Health Information Technology
  • Physician Investigator, Pacific Health Research and Education Institute

Publications

  1. US Preventive Services Task Force (USPSTF)
    1. US Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Caughey AB, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Tseng CW, Wong JB. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2022 May 10;327(18):1806-1811. PMID: 35536260
    2. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Krist AH, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Tseng CW, Wong JB. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2022 Apr 26;327(16):1577-1584. doi: 10.1001/jama.2022.4983.PMID: 35471505
    3. US Preventive Services Task Force, Davidson KW, Mangione CM, Barry MJ, Nicholson WK, Cabana MD, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Collaboration and shared decision-making between patients and clinicians in preventive health care decisions and US Preventive Services Task Force Recommendations. JAMA. 2022 Mar 22;327(12):1171-1176. PMID: 35315879.
    4. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Epling JW Jr, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for atrial fibrillation: US Preventive Services Task Force Recommendation Statement. JAMA. 2022 Jan 25;327(4):360-367. PMID: 35076659.
    5. US Preventive Services Task Force, Davidson KW, Mangione CM, Barry MJ, Cabana MD, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Simon M, Stevermer J, Tseng CW, Wong JB. Actions to Transform US Preventive Services Task Force Methods to Mitigate Systemic Racism in Clinical Preventive Services.
      JAMA. 2021 Dec 21;326(23):2405-2411. PMID: 34747970
    6. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB.JAMA. Screening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years: US Preventive Services Task Force Recommendation Statement.
      2021 Dec 7;326(21):2172-2178. PMID: 34874412
    7. Davidson KW, Krist AH, Tseng CW, Simon M, Doubeni CA, Kemper AR, Kubik M, Ngo-Metzger Q, Mills J, Borsky A. Incorporation of Social Risk in US Preventive Services Task Force Recommendations and Identification of Key Challenges for Primary Care .JAMA. 2021 Oct 12;326(14):1410-1415. PMID: 34468692
    8. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Stevermer J, Tseng CW, Wong JB. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.
      JAMA. 2021 Sep 28;326(12):1186-1191. PMID: 34581729
    9. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Stevermer J, Tseng CW, Wong JB. Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Sep 14;326(10):949-956. PMID: 34519796
    10. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Aug 24;326(8):736-743. PMID: 34427594
    11. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Aug 10;326(6):531-538 .PMID: 34374716
    12. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Simon M, Stevermer J, Tseng CW, Wong JB. Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 May 25;325(20):2087-2093. PMID: 34032823
    13. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Krist AH, Kubik M, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 May 18;325(19):1965-1977. PMID: 34003218
    14. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2021 Apr 27;325(16):1650-1656. PMID: 33904861
    15. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Epling JW Jr, Kubik M, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Apr 13;325(14):1436-1442. PMID: 33847711
    16. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Epling JW Jr, Kubik M, Li L, Ogedegbe G, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Hearing Loss in Older Adults: US Preventive Services Task Force Recommendation Statement. .JAMA. 2021 Mar 23;325(12):1196-1201. doi: 10.1001/jama.2021.2566.PMID: 33755083
    17. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Landefeld CS, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Mar 9;325(10):962-970. doi: 10.1001/jama.2021.1117.PMID: 33687470
    18. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Feb 2;325(5):476-481. doi: 10.1001/jama.2020.26988.PMID: 33528542
    19. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA. 2021 Jan 19;325(3):265-279. doi: 10.1001/jama.2020.25019.PMID: 33464343
    20. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Dec 15;324(23):2415-2422. doi: 10.1001/jama.2020.22980.PMID:33320230.
    21. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Landefeld S, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Nov 24;324(20):2069-2075. doi: 10.1001/jama.2020.21749. PMID: 33231670.
    22. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for High Blood Pressure in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Nov 10;324(18):1878-1883. doi: 10.1001/jama.2020.20122.PMID: 33170248
    23. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Behavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Aug 18;324(7):674-681. doi: 10.1001/jama.2020.13095.PMID: 32809008
    24. Davidson KW, Kemper AR, Doubeni CA, Tseng CW, Simon MA, Kubik M, Curry SJ, Mills j, Krist A, Ngo-Metzger Q, Borsky A. Developing primary care-based recommendations for social determinants of health: methods of the U.S. Preventive Services Task Force. Ann Intern Med. 2020 Sep 15;173(6):461-467. doi: 10.7326/M20-0730. Epub 2020 Jul 14. PMID:32658576.
    25. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Curry SJ, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Jun 9;323(22):2301-2309. doi: 10.1001/jama.2020.8020. PubMed PMID: 32515821.
    26. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Primary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 May 26;323(20):2060-2066. doi: 10.1001/jama.2020.6774. PubMed PMID: 32453374.
    27. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(24):2521‐2531. doi:10.1001/jama.2018.7498
    28. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement [published correction appears in JAMA. 2018 Jun 19;319(23):2443]. JAMA. 2018;319(18):1901‐1913. doi:10.1001/jama.2018.3710
    29. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674‐686. doi:10.1001/jama.2018.10897
    30. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Interventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(16):1696‐1704. doi:10.1001/jama.2018.3097
    31. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement [published correction appears in JAMA. 2019 Nov 12;322(18):1830]. JAMA. 2019;322(7):652‐665. doi:10.1001/jama.2019.10987
    32. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(15):1592‐1599. doi:10.1001/jama.2018.3185
    33. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(11):1163‐1171. doi:10.1001/jama.2018.13022
    34. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(6):580‐587. doi:10.1001/jama.2019.0007
    35. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(22):2203‐2213. doi:10.1001/jama.2019.6390
    36. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(9):857‐867. doi:10.1001/jama.2019.11885
    37. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(6):588‐594. doi:10.1001/jama.2017.21926
    38. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2019;322(5):438‐444. doi:10.1001/jama.2019.10232
    39. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(12):1188‐1194. doi:10.1001/jama.2019.13069
    40. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(2):177‐183. doi:10.1001/jama.2018.8357
    41. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement. JAMA. 2018;320(16):1678‐1687. doi:10.1001/jama.2018.14741
    42. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2019;321(4):394‐398. doi:10.1001/jama.2018.21367
    43. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(23):2326‐2336. doi:10.1001/jama.2019.6587
    44. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(22):2211‐2218. doi:10.1001/jama.2019.18928
    45. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(20):2122‐2128. doi:10.1001/jama.2018.17772
    46. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Screening for Adolescent Idiopathic Scoliosis: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(2):165‐172. doi:10.1001/jama.2017.19342
    47. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(11):1134‐1142. doi:10.1001/jama.2018.1623
    48. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Syphilis Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2018;320(9):911‐917. doi:10.1001/jama.2018.11785
    49. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Elevated Blood Lead Levels in Children and Pregnant Women: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;321(15):1502‐1509. doi:10.1001/jama.2019.3326
    50. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement [published correction appears in JAMA. 2019 Sep 17;322(11):1108]. JAMA. 2019;322(4):349‐354. doi:10.1001/jama.2019.9365
    51. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(3):272‐280. doi:10.1001/jama.2018.8359
    52. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(18):1899‐1909. doi:10.1001/jama.2018.16789
    53. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(5):478‐484. doi:10.1001/jama.2018.10321
    54. Krist AH, Wolff TA, Jonas DE, et al. Update on the Methods of the U.S. Preventive Services Task Force: Methods for Understanding Certainty and Net Benefit When Making Recommendations. Am J Prev Med. 2018;54(1S1):S11‐S18. doi:10.1016/j.amepre.2017.09.011
    55. US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(22):2308‐2314. doi:10.1001/jama.2018.6848
    56. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(8):757‐763. doi:10.1001/jama.2020.0435
    57. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement [published online ahead of print, 2020 Mar 2]. JAMA. 2020;10.1001/jama.2020.1123. doi:10.1001/jama.2020.1123
    58. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(13):1286‐1292. doi:10.1001/jama.2020.2684
    59. US Preventive Services Task Force, Owens DK, Davidson KW, et al. Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(16):1590‐1598. doi:10.1001/jama.2020.4679
    60. Kurth AE, Krist AH, Borsky AE, et al. U.S. Preventive Services Task Force Methods to Communicate and Disseminate Clinical Preventive Services Recommendations. Am J Prev Med. 2018;54(1S1):S81‐S87. doi:10.1016/j.amepre.2017.07.004
    61. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;318(22):2224‐2233. doi:10.1001/jama.2017.18261
    62. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Vision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;318(9):836‐844. doi:10.1001/jama.2017.11260
    63. US Preventive Services Task Force, Grossman DC, Bibbins-Domingo K, et al. Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;318(2):167‐174. doi:10.1001/jama.2017.7171
    64. US Preventive Services Task Force, Grossman DC, Bibbins-Domingo K, et al. Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(23):2417‐2426. doi:10.1001/jama.2017.6803
    65. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(18):1882‐1887. doi:10.1001/jama.2017.4011
    66. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(16):1661‐1667. doi:10.1001/jama.2017.3439
    67. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(12):1252‐1257. doi:10.1001/jama.2017.1462
    68. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(9):947‐953. doi:10.1001/jama.2017.0807
    69. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(4):407‐414. doi:10.1001/jama.2016.20325
    70. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(2):183‐189. doi:10.1001/jama.2016.19438
    71. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;316(23):2525‐2530. doi:10.1001/jama.2016.16776
  2. Non-USPSTF Publications
    1. Barry MJ, Tseng CW. Moving to more evidence-based primary care encounters: a farewell to the review of systems. JAMA. 2022; 328(15):1495-1496.
    2. Chiu N, Aggarwal R, Hernandez I, Wadhera R, Dejong C, Tseng CW, Yeh RW, Kazi DS. Spending on insulin by U.S. payers and patients from 2008 to 2017. Diab Care. 2022 Aug 30;dc220054. doi: 10.2337/dc22-0054.
    3. Soin K, Kobayashi L, Quattlebaum T, Tseng CW. Exploring barriers to LARC placement training for family medicine residents. Ann Fam Med. April 2022; 20 (Supplement 1): 3250.
    4. Quattlebaum T, Soin K, Tseng CW, Murata K. Impact of virtual morning report on learning and well-being during the COVID-19 pandemic. Ann of Fam Med. April 2022; 20 (Supplement 1): 3216.
    5. Rolita L, Galiza J, Chen J, Siriwardhana C, Tseng CW, Buenconsejo-Lum L. Quality improvement projects as training tools for family medicine residents and faculty. Hawaii J Health Soc Welf. 2022 Apr; 81(4):94-100. PMID: 35415616
    6. Masuda C, Huynh T, Wong V, DeJong C, Tseng CW. A pilot program to teach pharmacy students practical skills to navigate drug insurance benefits. Pharmacy. 2022 Jan 27;10(1):23. PMID: 35202072.
    7. Tseng CW, Roh Y, DeJong C, Kanagusuku LN, Soin KS. Patients’ compliance with quarantine requirements for exposure or potential symptoms of COVID-19. Hawaii J Health Soc Welf. 2021 Nov; 80(11):276-282.PMID: 34765987.
    8. Hartung DM, Johnston KA, Bourdette DN, Chen R, Tseng CW. Closing the Part D coverage gap and out-of-pocket costs for multiple sclerosis drugs. Neurol Clin Pract. 2021 Aug;11(4):298-303. PMID: 34484929
    9. DeJong C, Kazi DS, Dudley RA, Chen R, Tseng CW. Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D [published online ahead of print, 2019 Jul 10]. JAMA Cardiol. 2019;4(8):828‐830. doi:10.1001/jamacardio.2019.2223
    10. Lin JS, Evans CV, Grossman DC, Tseng CW, Krist AH. Framework for Using Risk Stratification to Improve Clinical Preventive Service Guidelines [published correction appears in Am J Prev Med. 2019 Oct;57(4):574]. Am J Prev Med. 2018;54(1S1):S26‐S37. doi:10.1016/j.amepre.2017.07.023
    11. Yazdany J, Dudley RA, Lin GA, Chen R, Tseng CW. Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D. JAMA. 2018;320(9):931‐933. doi:10.1001/jama.2018.7316
    12. Kemper AR, Krist AH, Tseng CW, et al. Challenges in Developing U.S. Preventive Services Task Force Child Health Recommendations. Am J Prev Med. 2018;54(1S1):S63‐S69. doi:10.1016/j.amepre.2017.08.023
    13. DeJong C, Tseng CW, Dudley RA. Important Distinctions Concerning Pharmaceutical Company-Sponsored Meals and Prescribing Patterns-Reply. JAMA Intern Med. 2016;176(12):1881. doi:10.1001/jamainternmed.2016.7157
    14. Kazi DS, Lu CY, Lin GA, et al. Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans. JAMA Cardiol. 2017;2(10):1164‐1166. doi:10.1001/jamacardio.2017.3051
    15. Tseng CW, Yazdany J, Dudley RA, et al. Medicare Part D Plans’ Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease. JAMA Intern Med. 2017;177(4):585‐588. doi:10.1001/jamainternmed.2016.9386
    16. Alexander GC, Tseng CW. Six strategies to identify and assist patients burdened by out-of-pocket prescription costs. Cleve Clin J Med. 2004;71(5):433‐437. doi:10.3949/ccjm.71.5.433
    17. Inouye J, Nichols A, Maskarinec G, Tseng CW. A survey of musculoskeletal injuries associated with Zumba. Hawaii J Med Public Health. 2013;72(12):433‐436.
    18. Yazdany J, Dudley RA, Chen R, Lin GA, Tseng CW. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D. Arthritis Rheumatol. 2015;67(6):1474‐1480. doi:10.1002/art.39079
    19. Tom JO, Mangione-Smith R, Grossman DC, Solomon C, Tseng CW. Well-child care visits and risk of ambulatory care-sensitive hospitalizations. Am J Manag Care. 2013;19(5):354‐360.
    20. Johnson SL, Tierney EF, Onyemere KU, Tseng CW,  Safford MM, Karter AJ, Ferrara A, Duru OK, Brown AF, Narayan KMV, Thompson T, Herman WH. Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2006 Aug;29:1733-38. PMID 16873772.
    21. Tseng CW, Omphroy G, Cruz L, Naval CL, Haddock RL. Cancer in the Territory of Guam. Pac Health Dialog. 2004;11(2):57‐63.
    22. DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries [published correction appears in JAMA Intern Med. 2016 Sep 1;176(9):1411-2]. JAMA Intern Med. 2016;176(8):1114‐1122. doi:10.1001/jamainternmed.2016.2765
    23. Tseng CW, Lin GA, Davis J, et al. Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study. BMC Health Serv Res. 2016;16(1):499. Published 2016 Sep 21. doi:10.1186/s12913-016-1752-4
    24. Sentell TL, Juarez DT, Ahn HJ, et al. Disparities in diabetes-related preventable hospitalizations among working-age Native Hawaiians and Asians in Hawai’i. Hawaii J Med Public Health. 2014;73(12 Suppl 3):8‐13.
    25. Duru OK, Ettner SL, Turk N, et al. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study. J Gen Intern Med. 2014;29(1):230‐236. doi:10.1007/s11606-013-2546-6
    26. Sentell TL, Ahn HJ, Juarez DT, et al. Comparison of potentially preventable hospitalizations related to diabetes among Native Hawaiian, Chinese, Filipino, and Japanese elderly compared with whites, Hawai’i, December 2006-December 2010 [published correction appears in Prev Chronic Dis. 2013;10:E143]. Prev Chronic Dis. 2013;10:E123. Published 2013 Jul 25. doi:10.5888/pcd10.120340
    27. Tseng CW, Masuda C, Chen R, Hartung DM. Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D. Diabetes Care. 2020;43(4):e50‐e51. doi:10.2337/dc19-1294
    28. Tseng CW, Brook RH, Alexander GC, et al. Health information technology and physicians’ knowledge of drug costs. Am J Manag Care. 2010;16(4):e105‐e110. Published 2010 Apr 1.
    29. Tseng CW, Waitzfelder BE, Tierney EF, et al. Patients’ willingness to discuss trade-offs to lower their out-of-pocket drug costs. Arch Intern Med. 2010;170(16):1502‐1504. doi:10.1001/archinternmed.2010.287
    30. Alexander GC, Casalino LP, Tseng CW, McFadden D, Meltzer DO. Barriers to patient-physician communication about out-of-pocket costs. J Gen Intern Med. 2004;19(8):856‐860. doi:10.1111/j.1525-1497.2004.30249.x
    31. Tseng CW, Buenconsejo-Lum L, Manlucu L, Hixon A. Physicians’ willingness and barriers to considering cost when prescribing. Hawaii Med J. 2006;65(11):318‐321.
    32. Bilik D, McEwen LN, Brown MB, et al. Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiol Drug Saf. 2010;19(7):715‐721. doi:10.1002/pds.1954
    33. Schmittdiel JA, Steers N, Duru OK, et al. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study. BMC Health Serv Res. 2010;10:164. Published 2010 Jun 14. doi:10.1186/1472-6963-10-164
    34. DeJong C, Masuda C, Chen R, Kazi DS, Dudley RA, Tseng CW. Out-of-pocket costs for novel guideline-directed diabetes therapies under Medicare Part D. JAMA Intern Med. 2020 Dec 1;180(12):1696-1699. PMID: 32926091
    35. Yang EJ, Galan E, Thombley R, Lin A, Seo J, Tseng CW, Resneck JS, Bach PB, Dudley RA.
      Changes in drug list prices and amounts paid by patients and insurers. JAMA Netw Open. 2020 Dec 1;3(12):e2028510. PMID: 33295971.
    36. Tseng CW, Dudley RA, Chen R, Walensky RP. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis. JAMA Netw Open. 2020;3(4):e202739. Published 2020 Apr 1. doi:10.1001/jamanetworkopen.2020.2739
    37. Crosson JC, Tseng CW, Duru OK, Fung V, Bazemore AW, Phillips RL. Medicare insurance gaps could lead to higher costs for payers and worse outcomes for patients. Am Fam Phys. 2011.
    38. Tom JO, Tseng CW, Davis J, Solomon C, Zhou C, Mangione-Smith R. Missed well-child care visits, low continuity of care, and risk of ambulatory care-sensitive hospitalizations in young children. Arch Pediatr Adolesc Med. 2010;164(11):1052‐1058. doi:10.1001/archpediatrics.2010.201
    39. Tseng CW. When patients cannot afford their medications. Am Fam Physician. 2004;70(3):605‐608.
    40. Tseng CW, Tierney EF, Gerzoff RB, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care. 2008;31(2):261‐266. doi:10.2337/dc07-1341
    41. Karter AJ, Stevens MR, Brown AF, et al. Educational disparities in health behaviors among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. BMC Public Health. 2007;7:308. Published 2007 Oct 29. doi:10.1186/1471-2458-7-308
    42. Tseng CW, Brook RH, Keeler E, Steers WN, Waitzfelder BE, Mangione CM. Effect of generic-only drug benefits on seniors’ medication use and financial burden. Am J Manag Care. 2006;12(9):525‐532.
    43. Crosson JC, Heisler M, Subramanian U, et al. Physicians’ perceptions of barriers to cardiovascular disease risk factor control among patients with diabetes: results from the translating research into action for diabetes (TRIAD) study. J Am Board Fam Med. 2010;23(2):171‐178. doi:10.3122/jabfm.2010.02.090125
    44. Duru OK, Gerzoff RB, Brown AF, et al. Predictors of sustained walking among diabetes patients in managed care: the Translating Research into Action for Diabetes (TRIAD) study. J Gen Intern Med. 2008;23(8):1194‐1199. doi:10.1007/s11606-008-0629-6
    45. Tseng CW, Mangione CM, Brook RH, Keeler E, Dudley RA. Identifying widely covered drugs and drug coverage variation among Medicare part D formularies. JAMA. 2007;297(23):2596‐2602. doi:10.1001/jama.297.23.2596
    46. Tseng CW, Brook RH, Keeler E, Mangione CM. Impact of an annual dollar limit or “cap” on prescription drug benefits for Medicare patients. JAMA. 2003;290(2):222‐227. doi:10.1001/jama.290.2.222
    47. Duru OK, Mangione CM, Hsu J, et al. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study. J Am Geriatr Soc. 2010;58(5):822‐828. doi:10.1111/j.1532-5415.2010.02813.x
    48. Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292(8):952‐960. doi:10.1001/jama.292.8.952
    49. Heisler M, Tierney E, Ackerman RT, Tseng CW, Narayan KMV, Crosson J, Waitzfelder BE, Safford MM, Duru OK, Herman WH, Kim C. Physicians’ participatory decision-making and quality of diabetes care processes and outcomes: results from the TRIAD study. Chronic Illness. 2009 Sept; 5(3):165-76.
    50. Patel MR, Coffman JM, Tseng CW, Clark NM, Cabana MD. Physician communication regarding cost when prescribing asthma medication to children. Clin Pediatr (Phila). 2009;48(5):493‐498. doi:10.1177/0009922808330110
    51. Tseng CW, Omphroy G, Songsong JM, Shearer R. Cancer in the Commonwealth of the Northern Marianas Islands (CNMI). Pac Health Dialog. 2004;11(2):23‐29.
    52. Kapur K, Tseng CW, Rastegar A, Carter GM, Keeler E. Medicare calibration of the clinically detailed risk information system for cost. Health Care Financ Rev. 2003;25(1):37‐54.
    53. Tseng CW, Dudley RA, Brook RH, et al. Elderly patients’ knowledge of drug benefit caps and communication with providers about exceeding caps. J Am Geriatr Soc. 2009;57(5):848‐854. doi:10.1111/j.1532-5415.2009.02244.x
    54. Gregg EW, Karter AJ, Gerzoff RB, et al. Characteristics of insured patients with persistent gaps in diabetes care services: the Translating Research into Action for Diabetes (TRIAD) study. Med Care. 2010;48(1):31‐37. doi:10.1097/MLR.0b013e3181bd4783
    55. Karter AJ, Stevens MR, Gregg EW, et al. Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study. Am J Public Health. 2008;98(2):365‐370. doi:10.2105/AJPH.2005.083501
    56. Tseng CW, Dudley RA, Brook RH, et al. Elderly patients’ preferences and experiences with providers in managing their drug costs. J Am Geriatr Soc. 2007;55(12):1974‐1980. doi:10.1111/j.1532-5415.2007.01445.x
    57. Tseng CW, Huntington J. Enoxaparin for the prevention of VT in acutely ill patients. J Fam Pract. 1999 Dec;48(12):940-1. PubMed PMID: 10628571.
    58. Tseng CW, Schriger D, Usatine R, Brook R. The need for Spanish-language training at UCLA. Acad Med. 1998 Mar;73(3):222-3. doi: 10.1097/00001888-199803000-00004. PubMed PMID: 9526443.
    59. Perlmutter SM, Cosman PC, Tseng C, Olshen RA, Gray RM, Li KCP, Bergin CJ. Medical image compression and vector quantization. Statistical Science 1998;13(1):30-53.
    60. Perlmutter SM, Tseng C, Cosman PC, Li KCP, Olshen RA, Gray RM. Measurement accuracy as a measure of image quality in compressed MR chest scan. Proceedings ICIP-9. 1994 Nov; volume 1:861-865
    61. Cosman PC, Davidson HC, Bergin CJ, Tseng CW, Moses LE, Riskin EA, Olshen RA, Gray RM. Thoracic CT images: effect of lossy image compression on diagnostic accuracy. Radiology 1994;190(2):517-24
    62. Cosman P, Tseng CW, Olshen R, Gray R, Li K, Bergin C, Riskin, E. Tree-structured vector quantization of CT chest scans: Image quality and diagnostic accuracy. IEEE/Transactions on Medical Imaging 1993;12(4)

Awards

  • Robert Wood Johnson Foundation Generalist Physician Faculty Scholars Program
  • United States Preventive Services Task Force Member (2016-2020)
Back To Top